HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sulforaphane attenuates EGFR signaling in NSCLC cells.

AbstractBACKGROUND:
EGFR, a receptor tyrosine kinase (RTK), is frequently overexpressed and mutated in non-small cell lung cancer (NSCLC). Tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of many cancers, including NSCLC. However, intrinsic and acquired resistance to TKI remains a common obstacle. One strategy that may help overcome EGFR-TKI resistance is to target EGFR for degradation. As EGFR is a client protein of heat-shock protein 90 (HSP90) and sulforaphane is known to functionally regulate HSP90, we hypothesized that sulforaphane could attenuate EGFR-related signaling and potentially be used to treat NSCLC.
RESULTS:
Our study revealed that sulforaphane displayed antitumor activity against NSCLC cells both in vitro and in vivo. The sensitivity of NSCLC cells to sulforaphane appeared to positively correlate with the inhibition of EGFR-related signaling, which was attributed to the increased proteasomal degradation of EGFR. Combined treatment of NSCLC cells with sulforaphane plus another HSP90 inhibitor (17-AAG) enhanced the inhibition of EGFR-related signaling both in vitro and in vivo.
CONCLUSIONS:
We have shown that sulforaphane is a novel inhibitory modulator of EGFR expression and is effective in inhibiting the tumor growth of EGFR-TKI-resistant NSCLC cells. Our findings suggest that sulforaphane should be further explored for its potential clinical applications against NSCLC.
AuthorsChi-Yuan Chen, Zhu-Yun Yu, Yen-Shu Chuang, Rui-Mei Huang, Tzu-Chien V Wang
JournalJournal of biomedical science (J Biomed Sci) Vol. 22 Pg. 38 (Jun 03 2015) ISSN: 1423-0127 [Electronic] England
PMID26036303 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Isothiocyanates
  • Sulfoxides
  • EGFR protein, human
  • ErbB Receptors
  • sulforaphane
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Carcinoma, Non-Small-Cell Lung (physiopathology)
  • Cell Line, Tumor
  • ErbB Receptors (genetics, metabolism)
  • Humans
  • Isothiocyanates (pharmacology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Random Allocation
  • Signal Transduction (drug effects)
  • Sulfoxides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: